Unjha Formulations FY26 Audited Results: Annual Net Profit Rises to ₹70.47 Lacs, Revenue at ₹1,574.87 Lacs
Unjha Formulations Limited reported audited standalone financial results for the quarter and year ended 31 March 2026, with annual net profit rising to ₹70.47 lacs from ₹40.76 lacs in FY25 and total income from operations growing to ₹1,574.87 lacs. The Q4 FY26 quarter recorded a net loss of ₹74.28 lacs, while total assets expanded to ₹551.04 lacs and cash and cash equivalents surged to ₹164.48 lacs. The board also approved the appointment of M/s Ajay Parikh & Associates as Secretarial Auditor for FY 2025-26.

*this image is generated using AI for illustrative purposes only.
Unjha Formulations Limited's Board of Directors convened on 18 May 2026 and approved the audited standalone financial results for the quarter and year ended 31 March 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also submitted an Integrated Filing (Financial) under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, read with BSE Circular No. 20250102-4 dated January 2, 2025. The board meeting commenced at 12.30 p.m. and concluded at 2.00 p.m. Statutory auditors Jain & Golechha, Chartered Accountants (FRN: 119637W), issued an unmodified audit opinion on the annual financial results.
Annual Financial Performance
For the full year ended 31 March 2026, Unjha Formulations recorded a meaningful improvement in both revenue and profitability compared to the previous year. Total income from operations rose to ₹1,574.87 lacs from ₹1,397.68 lacs in FY25, while net profit for the period grew to ₹70.47 lacs from ₹40.76 lacs. The following table summarises the key annual financial metrics (all figures in Rs. in Lacs):
| Metric: | FY26 (Audited) | FY25 (Audited) |
|---|---|---|
| Net Sales/Income from Operations: | ₹1,558.52 | ₹1,386.21 |
| Other Operating Income: | ₹16.36 | ₹11.47 |
| Total Income from Operations (Net): | ₹1,574.87 | ₹1,397.68 |
| Total Expenditure: | ₹1,479.49 | ₹1,345.32 |
| Profit from Operations (before other income, finance cost & exceptional items): | ₹95.38 | ₹52.36 |
| Net Profit for the Period: | ₹70.47 | ₹40.76 |
| Total Comprehensive Income: | ₹70.47 | ₹40.76 |
| Basic EPS (₹, not annualised): | ₹1.57 | ₹0.91 |
| Diluted EPS (₹, not annualised): | ₹1.57 | ₹0.91 |
Quarterly Financial Performance
For the quarter ended 31 March 2026, the company reported total income from operations of ₹332.82 lacs, compared to ₹443.90 lacs in the preceding quarter ended 31 December 2025 and ₹243.90 lacs in the corresponding quarter of the previous year. The quarter recorded a net loss of ₹74.28 lacs, against a net profit of ₹23.97 lacs in Q3 FY26 and a net loss of ₹40.64 lacs in Q4 FY25. Key quarterly metrics are presented below (all figures in Rs. in Lacs):
| Metric: | Q4 FY26 (31.03.2026) | Q3 FY26 (31.12.2025) | Q4 FY25 (31.03.2025) |
|---|---|---|---|
| Total Income from Operations (Net): | ₹332.82 | ₹443.90 | ₹243.90 |
| Total Expenditure: | ₹382.19 | ₹419.93 | ₹272.94 |
| Profit/(Loss) from Operations: | -₹49.37 | ₹23.97 | -₹29.04 |
| Net Profit/(Loss) for the Period: | -₹74.28 | ₹23.97 | -₹40.64 |
| Basic EPS (₹, not annualised): | -₹1.66 | ₹0.53 | -₹0.91 |
| Diluted EPS (₹, not annualised): | -₹1.66 | ₹0.53 | -₹0.91 |
Balance Sheet Highlights
As at 31 March 2026, the company's total assets stood at ₹551.04 lacs, up from ₹455.74 lacs as at 31 March 2025. Cash and cash equivalents increased significantly to ₹164.48 lacs from ₹64.38 lacs in the prior year. Equity share capital remained unchanged at ₹448.05 lacs. Key balance sheet figures are as follows (all figures in Rs. in Lacs):
| Parameter: | 31.03.2026 (Audited) | 31.03.2025 (Audited) |
|---|---|---|
| Total Non-Current Assets: | ₹129.84 | ₹120.22 |
| Total Current Assets: | ₹421.19 | ₹335.52 |
| Total Assets: | ₹551.04 | ₹455.74 |
| Equity Share Capital: | ₹448.05 | ₹448.05 |
| Other Equity: | -₹63.71 | -₹134.17 |
| Total Non-Current Liabilities: | ₹0.00 | ₹0.48 |
| Total Current Liabilities: | ₹166.70 | ₹141.37 |
| Total Equity and Liabilities: | ₹551.04 | ₹455.74 |
Cash Flow Summary
The company generated net cash from operating activities of ₹124.38 lacs for the year ended 31 March 2026, a marked improvement compared to a net cash outflow of ₹(4.49) lacs in the prior year. Net cash used in investing activities was ₹(23.49) lacs, primarily on account of purchase of property, plant and equipment worth ₹(23.49) lacs. Net cash used in financing activities stood at ₹(0.79) lacs. As a result, cash and cash equivalents at the end of the period rose to ₹164.48 lacs from ₹64.38 lacs at the beginning of the period.
Corporate Developments
At the same board meeting, the Board, on the recommendation of the Audit Committee, approved the appointment of M/s Ajay Parikh & Associates, Company Secretaries, Ahmedabad, as the Secretarial Auditor of the company to conduct the Secretarial Audit for FY 2025-26. The statutory auditors, Jain & Golechha, Chartered Accountants, issued an audit report with an unmodified opinion in respect of the annual audited standalone results for the year ended 31 March 2026, in accordance with SEBI Circular No. CIR/CFD/CMD/56/2016 dated 27 May 2016. The company operates in a single business segment, and accordingly, the reported figures represent the performance of that segment.
Historical Stock Returns for Unjha Formulations
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.21% | +1.47% | -7.96% | -24.87% | -16.09% | +100.21% |
What specific operational or cost-side factors drove the sharp Q4 FY26 net loss of ₹74.28 lacs despite full-year profitability, and can management address these seasonality risks in FY27?
With other equity still deeply negative at -₹63.71 lacs, what is Unjha Formulations' timeline and strategy for fully eliminating accumulated losses and achieving a positive net worth?
Given the significant cash build-up to ₹164.48 lacs, how does the company plan to deploy this liquidity — through capacity expansion, product diversification, or potential acquisitions — to sustain revenue growth beyond FY26?
































